PA
Perceptive Advisors’s Athira Pharma ATHA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.63M | Hold |
5,402,964
| – | – | 0.06% | 71 |
|
|
2025
Q1 | $1.54M | Hold |
5,402,964
| – | – | 0.05% | 74 |
|
|
2024
Q4 | $3.17M | Hold |
5,402,964
| – | – | 0.09% | 78 |
|
|
2024
Q3 | $2.41M | Hold |
5,402,964
| – | – | 0.05% | 85 |
|
|
2024
Q2 | $14.3M | Hold |
5,402,964
| – | – | 0.34% | 61 |
|
|
2024
Q1 | $14.8M | Hold |
5,402,964
| – | – | 0.26% | 67 |
|
|
2023
Q4 | $13.1M | Buy |
5,402,964
+605,686
| +13% | +$1.47M | 0.29% | 61 |
|
|
2023
Q3 | $9.69M | Hold |
4,797,278
| – | – | 0.32% | 58 |
|
|
2023
Q2 | $14.2M | Hold |
4,797,278
| – | – | 0.41% | 60 |
|
|
2023
Q1 | $12M | Hold |
4,797,278
| – | – | 0.35% | 60 |
|
|
2022
Q4 | $15.2M | Hold |
4,797,278
| – | – | 0.43% | 48 |
|
|
2022
Q3 | $14.2M | Hold |
4,797,278
| – | – | 0.41% | 56 |
|
|
2022
Q2 | $14.6M | Buy |
4,797,278
+1,371,362
| +40% | +$4.18M | 0.46% | 49 |
|
|
2022
Q1 | $46.3M | Hold |
3,425,916
| – | – | 0.93% | 28 |
|
|
2021
Q4 | $44.6M | Hold |
3,425,916
| – | – | 0.69% | 36 |
|
|
2021
Q3 | $32.1M | Hold |
3,425,916
| – | – | 0.47% | 53 |
|
|
2021
Q2 | $35.1M | Hold |
3,425,916
| – | – | 0.46% | 54 |
|
|
2021
Q1 | $63M | Buy |
3,425,916
+311,111
| +10% | +$5.72M | 0.8% | 31 |
|
|
2020
Q4 | $107M | Hold |
3,114,805
| – | – | 1.14% | 23 |
|
|
2020
Q3 | $57.5M | Buy |
+3,114,805
| New | +$57.5M | 0.84% | 33 |
|